Abstract:Dear Editor, We appreciate the opportunity to respond to the letter to the editor regarding our research comparing combined Foley catheter with vaginal misoprostol with Foley catheter or vaginal misoprostol alone.1 They expressed concerns regarding clarity of some terms and the high caesarean section (CS) rates reported. First, a concern about the definition of the primary outcome measure was raised, equating rate of vaginal delivery and successful induction of labour. ‘Successful induction of labour’ has been defined as a vaginal delivery within 24–48 h of induction of labour.2 Therefore, vaginal delivery is used as a measure of successful induction of labour. Hence, rate of successful induction and vaginal delivery are one and the same thing. Second, clarity about the definition of failed induction of labour was raised and reference was made to Table 2 of the article. Failed induction of labour is defined as the inability to achieve cervical dilation > 4 cm after 12 h of oxytocin administration with a goal of three contractions in 10 min.3 Third, concerns were raised about the CS rates reported in the study. We acknowledge the fact the CS rate recorded in this study was higher than the rates reported in the PROBAAT studies4,5 and as noted by the authors too that the CS rate from the PROBAAT studies is the lowest reported from such powered randomised studies. However, the CS rate from this study is comparable and lower than CS rate reported by Chung et al.6 and Kashanian et al.7 respectively. This difference in rates may be related to the fact that this study was performed in a tertiary institution which serves as a referral centre to both primary and secondary health care facilities in neighbouring communities. This accounts for the high rate of high-risk pregnancies and the high CS rate recorded from the study. Also, fetal distress in this study was suspected based on persistent non-reassuring fetal heart tracing on a cardiotocographic machine, and this may have also contributed to the CS rate. The 24 h vaginal delivery rate used in this study as opposed to the 48 h delivery rate used in the PROBAAT studies may also account for the difference. Finally, the authors referred to the timing of amniotomy and oxytocin administration as aggressive. Amniotomy and oxytocin administration followed standardised departmental protocol as written in the study. Oxytocin augmentation was only required in patients with inadequate contractions with the aim of achieving 3–5 contractions in 10 min, each lasting for 40–60 s while all patients had amniotomy when the cervix was ≥ 4 cm. Since the shorter time to delivery between the combined and individual therapies was also found by a larger MOMI trial,8 we agree with the authors that combined prostaglandin and cervical catheter will have a place in the medical armamentarium for cervical ripening. We commend the authors for the critical review of our article.

Influence of IGF-1 on MMP and TIMP expression in human renal interstitial fibroblasts

Abnormal expression of IGF-binding proteins, an initiating event in idiopathic pulmonary fibrosis?

Effects of Imidaprilat on Matrix Metalloproteinase - 2 and TIMP - 2 in Human Cardiac Fibroblasts

[Interleukin-1Beta Upregulates Matrix Metalloproteinase-2 Expression and Activity in Cardiac Fibroblasts Via Nitric Oxide Synthase Pathway].

[Effect of Interferon-Gamma on Transforming Growth Factor Beta/smad Signal Pathway and Expression of Matrix Metalloproteinase-2 and Tissue Inhibitors of Matrix Metalloproteinase-2 in Cultured Rat Mesangial Cells].

TNF-α and IL-1β–mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells

Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors

[Expression of Matrix Metalloproteinase-2 And-9 in Kidney of Diabetic Rats].

THE EFFECT OF INTERLEUKIN-1β ON RENAL TUBULAR EPITHELIAL-MYOFIBROBLAST TRANSDIFFERENTIATION INDUCED BY HIGH GLUCOSE

Relationship Between Expression of Α Smooth Muscle Actin and Diabetic Nephropathy in Rats

[Connective Tissue Growth Factor Synergistically with Transforming Growth Factor Beta 1 to Promote Renal Fibrosis].

Influence of Qizhi Yifei Containing Serum on Regulating Expression of MMP-9 and TIMP-1 mRNA in Rat Ffibroblasts Stimulated by TGF-β1

[Changes of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in the Bronchoalveolar Lavage Fluid and the Serum of Patients with Idiopathic Pulmonary Fibrosis].

Combined Foley's catheter with vaginal misoprostol for pre‐induction cervical ripening: A randomised controlled trial

Role of IGF-1R in Epithelial–mesenchymal Transdifferentiation of Human Peritoneal Mesothelial Cells

Aberrant leucocytozoon infection in parakeets

[Hypoxia Induces the Expression and Secretion of Connective Tissue Growth Factor and Fibronectin by Cultured Renal Cortical Myofibroblasts].

Effects of Transforming Growth Factor-β1 on Renal Extracellular Matrix Components and Their Regulating Proteins

Connective tissue growth factor increases matrix metalloproteinase-2 and suppresses tissue inhibitor of matrix metalloproteinase-2 production by cultured renal interstitial fibroblasts.

Insulin-like growth factor binding protein-related protein 1 contributes to hepatic fibrogenesis

[Expression of Transforming Growth Factor-Beta1 in Renal Fibrosis of Human Mesengial Proliferative Glomerulonephritis].